Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperkalemia occurrence after MINNEBRO in hypertension (MID-NET cohort)
jRCT2031210423Recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of esaxerenone in hypertension (HTN) (2 cohorts), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Development of hyperkalemia. Started Jan 2009; status: recruiting.
02
Drugs
esaxerenone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on jRCT2031210423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210423.